All
The National Lipid Association and the Foundation are thankful once again for another successful year of meetings and fundraising. But we still have much work to do. The Foundation hosted the NLA’s 15th Anniversary Celebration Gala this past May in conjunction with the NLA Annual... more
Are you interested in becoming certified in Clinical Lipidology? The Summer exam dates are July 8 – August 24 for the American Board of Clinical Lipidology and the Accreditation Council for Clinical Lipidology. Apply by July 5.
The Foundation of the National Lipid Association continues to make strides to help educate and promote clinical lipidology — both to clinicians and to the public. In the last Foundation Update, we discussed the launch of “Cholesterol Counts,” an unbranded cholesterol awareness campaign geared... more
The NLA today announced the release of its official scientific statement on CAC scoring to guide prevention of ASCVD.
Join the Cardiometabolic Work Group! The functions of the Cardiometabolic Work Group include: The section will be asked to propose topics and speakers for meetings Raise awareness among the membership and potential NLA members about the section... more
Overview Meet WHG News Articles Resources Contact WHG Chair: Merle Myerson MD, EdD, FACC, FNLA Co-Chairs Robert Wild MD, PhD, MPH, FNLA, Eliot Brinton MD, FAHA, FNLA. Meetings: in-person twice a year at NLA Sessions -- June and September Web meetings – December, March... more
The National Lipid Association ("NLA") respects your privacy. All personal information that is provided to the NLA is stored in a secure database and is restricted to designated NLA staff who have a "need to know" such information. The NLA will not disclose, give, sell, or transfer your personal... more
Please fill out all form fields, everything is required for submission. Thank you for your participation in the NLA.
Cardiovascular disease (CVD) remains the #1 killer of American men and women. Following recognition of the large gap between deaths of women as compared to men in the year 2000, there was subsequent intense focus on prevention of CVD in women. Following the launch of campaigns such as Go Red by the... more
Fabry’s Disease and Morquio A syndrome are two rare genetic diseases that lead to a diverse series of problems including cardiovascular.(1,30) Until recently, treatment options have been limited to treat these conditions. Now that there are available therapies to help improve quality and quantity... more


.png)







